ZIMMER BIOMET HOLDINGS, INC.
ZIMMER BIOMET HOLDINGS, INC.
WARSAW, IN
Loading...
Price History
Market Data
| Market Cap | -24.93M |
| P/E Ratio | - |
| P/B Ratio | -0.00 |
| EPS | - |
| Dividend Yield | 1.16% |
| D/E Ratio | 0.82 |
| Current Ratio | 1.98 |
| Currency | USD |
Key Financial Metrics
8.23B
Revenue
705.00M
Net Income
-
EPS (Diluted)
2.48B
Free Cash Flow
Profitability
Gross Margin
69.7%
Operating Margin
13.3%
Net Profit Margin
8.6%
EBITDA
2.97B
Returns & Efficiency
Return on Assets (ROA)
3.1%
Return on Equity (ROE)
5.6%
Dividend Yield
1.16%
EPS
-
Financial Health
Total Assets
23.09B
Total Debt
6.93B
Debt to Equity
0.82x
Current Ratio
1.98
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | WARSAW, IN |
| Fiscal Year | 2025 |
Peers
160.12B
P/E: --
47.87B
P/E: --
STERIS PLC
STE
21.07B
P/E: --
ALIGN TECHNOLOGY INC
ALGN
12.49B
P/E: --
6.92B
P/E: --
MSA SAFETY INC
MNESP
6.92B
P/E: --
2.22B
P/E: --
ENOVIS CORP
ENOV
1.43B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$-24.93M
P/E Ratio (TTM)-
Price to Book-0.00
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin69.7%
Operating Margin13.3%
Net Margin8.6%
ROE5.6%
ROA3.1%
Leverage & Liquidity
Debt to Equity0.82
Current Ratio1.98
Total Debt$6.93B
Total Assets$23.09B
Stockholders' Equity$12.70B
Income Statement (FY 2025)
Revenue$8.23B
Gross Profit$5.74B
Operating Income$1.10B
Net Income$705.00M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$2.48B
Cash & Equivalents$591.90M
Revenue Growth0.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 345 EAST MAIN STREET WARSAW, IN 46580 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 134151777 |
| Fiscal Year End | 1231 |
| Shares Outstanding | -300,000.00 |
| Stockholders' Equity | $12.70B |
| Cash & Equivalents | $591.90M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-28
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-28
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-01
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-01
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-01
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ZIMMER BIOMET HOLDINGS, INC. |
| Ticker | ZBH |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | WARSAW, IN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | -24.93M |
| Revenue | 8.23B |
| Net Income | 705.00M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 8.6% |
| ROE | 5.6% |
| Dividend Yield | 1.16% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...